China Regenerative Medicine International (HKSE:08158) Change In Receivables : HK$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is China Regenerative Medicine International Change In Receivables?

China Regenerative Medicine International's change in receivables for the quarter that ended in Dec. 2024 was HK$0.00 Mil. It means China Regenerative Medicine International's Accounts Receivable stayed the same from Jun. 2024 to Dec. 2024 .

China Regenerative Medicine International's change in receivables for the fiscal year that ended in Dec. 2024 was HK$0.57 Mil. It means China Regenerative Medicine International's Accounts Receivable declined by HK$0.57 Mil from Dec. 2023 to Dec. 2024 .

China Regenerative Medicine International's Accounts Receivable for the quarter that ended in Dec. 2024 was HK$0.62 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. China Regenerative Medicine International's liquidation value for the three months ended in Dec. 2024 was HK$-87.23 Mil.

China Regenerative Medicine International Change In Receivables Historical Data

The historical data trend for China Regenerative Medicine International's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Regenerative Medicine International Change In Receivables Chart

China Regenerative Medicine International Annual Data

Trend

Apr15

Apr16

Apr17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Receivables

Get a 7-Day Free Trial

-0.93

-0.13

0.14

-1.13

0.57

China Regenerative Medicine International Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Dec24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

China Regenerative Medicine International Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

China Regenerative Medicine International (HKSE:08158) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

China Regenerative Medicine International's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.622	/	0	*	91
=

2. In Ben Graham's calculation of liquidation value, China Regenerative Medicine International's accounts receivable are only considered to be worth 75% of book value:

China Regenerative Medicine International's liquidation value for the quarter that ended in Dec. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	22.702	-	110.512	+	0.75 * 0.622	+	0.5 * 0.236
=	-87.23

China Regenerative Medicine International Change In Receivables Related Terms

Thank you for viewing the detailed overview of China Regenerative Medicine International's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

China Regenerative Medicine International Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Regenerative Medicine International Ltd (HKSE:08158) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

132 Nathan Road, Suite 2310-18, Miramar Tower, Tsim Sha Tsui, Kowloon, HKG

Website

https://www.crmi.hk

China Regenerative Medicine International Ltd is an investment holding company engaged in the provision of healthcare products and services. Its reportable segments are Aesthetic medical and beauty services and Medical services. The vast majority of the company's revenue is derived from its Aesthetic medical and beauty services segment. Geographically, the People's Republic of China accounts for the majority of the revenue. It also has a presence in Hong Kong.

Executives

Central Huijin Investment Ltd.	2201 Interest of corporation controlled by you
Wang Chuang	2101 Beneficial owner
Arab Osman Mohammed	2501 Other
Wong Kwok Keung	2501 Other
Lei Changjuan	2101 Beneficial owner
Chang Zhou Shi Zhong Min Xing Kong Qi Ye Guan Li Zi Xun Fu Wu He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Kong Yudong	2101 Beneficial owner
Chang Zhou Shi Yao Guang Qi Ye Guan Li Zi Xun He Huo Qi Ye You Xian He Huo	2201 Interest of corporation controlled by you
Li Ren	2201 Interest of corporation controlled by you
Nat-ace Wood Industry Ltd. (formerly Known As Forerunner Technology Limited)	2201 Interest of corporation controlled by you
All Favour Holdings Limited	2101 Beneficial owner
Deng Shufen	2202 Interest of your spouse
Dai Yumin	2201 Interest of corporation controlled by you
Wang Xiaogang	2101 Beneficial owner
China Orient Asset Management Co., Ltd.	2106 Person having a security interest in shares

China Regenerative Medicine International Headlines

No Headlines